Small Sized Super Rapid Test Automated Chemiluminescence Immunoassay Analyzer
This product is no longer promoted on Made-in-China.com. If you find any infringement or
sensitive information of it, please contact us
for
handling. Thank you.
Similar Items
Loading...
You May Like
Loading...
Product Description
Company Info
Address:
197 Yaogu Avenue, Jiangbei New District, Nanjing
Business Type:
Manufacturer/Factory, Trading Company
Business Range:
Chemicals, Health & Medicine, Industrial Equipment & Components
Management System Certification:
ISO 9001, ISO 13485
Company Introduction:
Nanjing Norman Biological Technology Co., Ltd is dedicated to R& D and manufacturing of in vitro diagnostic instruments and reagents. Founded in 2008, Norman biological has been upholding the idea that R& D shapes future, and concentration determines success. Ever since the beginning, Norman has been focusing on developing and manufacturing chemiluminescence and immunofluorescence reagents.
Norman′s manufacture center is located in the Yuhua District and owns an over 2, 000m2 GMP-approved clean workshop. Now, the R& D base, which is over 2, 000m2, located in State-level New Jiangbei District, possesses over 100 R& D engineers, 40% of whom holding a PhD or Master degree.
Powered by advanced technology and excellent talents in the IVD field, Norman has been consistently improving its innovation platform, and increasing R& D investment. Self-innovation, combined with long-term strategic cooperation with universities, research institutes and foreign technologies, ensures consistent improvement on product quality. Norman′s R& D field, including instruments, reagents, and raw materials, was entrusted by the Nanjing government to build a R& D center specialized in biochemistry and immunity diagnosis.
Being an expert in automated chemiluminescence analysis, Norman owns independent and completed intellectual property rights. In addition, Norman′s products provide top-notch sensitivity, precision and accuracy. Thanks to the self-developed antigens and self-manufactured antibodies, Norman′s products feature in minimized intra-and inter- batch difference.
After 8-year rapid development, Norman is constructing a global R& D center, occupied over 30, 000m2, which will hold more than 1, 000 R& D engineers in the future.
R& D shapes future, and concentration determines success. Driven by the commitment to "provide thorough solution to improve human health", Norman will consistently do its utmost to drive the IVD industry forward and contribute more to human health.
Norman′s manufacture center is located in the Yuhua District and owns an over 2, 000m2 GMP-approved clean workshop. Now, the R& D base, which is over 2, 000m2, located in State-level New Jiangbei District, possesses over 100 R& D engineers, 40% of whom holding a PhD or Master degree.
Powered by advanced technology and excellent talents in the IVD field, Norman has been consistently improving its innovation platform, and increasing R& D investment. Self-innovation, combined with long-term strategic cooperation with universities, research institutes and foreign technologies, ensures consistent improvement on product quality. Norman′s R& D field, including instruments, reagents, and raw materials, was entrusted by the Nanjing government to build a R& D center specialized in biochemistry and immunity diagnosis.
Being an expert in automated chemiluminescence analysis, Norman owns independent and completed intellectual property rights. In addition, Norman′s products provide top-notch sensitivity, precision and accuracy. Thanks to the self-developed antigens and self-manufactured antibodies, Norman′s products feature in minimized intra-and inter- batch difference.
After 8-year rapid development, Norman is constructing a global R& D center, occupied over 30, 000m2, which will hold more than 1, 000 R& D engineers in the future.
R& D shapes future, and concentration determines success. Driven by the commitment to "provide thorough solution to improve human health", Norman will consistently do its utmost to drive the IVD industry forward and contribute more to human health.